<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[progression Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/progression.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to progression]]></description>
	<s:counts start="0" returned="20" found="26" />
	<language>en-us</language>
	<item>
		<title><![CDATA[inVentiv Health Inc. F4Q08 and Full Year 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14031_23-273296.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from Eugene Mannheimer with Auriga USA.  Eugene Mannheimer - Auriga USA   I have a question on the guidance.  In terms of commercial services does your guidance contemplate any new sales team wins or wind downs in...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 26 Feb 2009 09:52:11 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[Progression]]></category>
		<category domain="http://resources.bnet.com/topic/guidance.html"><![CDATA[Guidance]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/caris+%2526+co..html"><![CDATA[Caris & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/inventiv+health+inc..html"><![CDATA[Inventiv Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VTIV</category>
		<category domain="tickers">VTIV</category>
	</item>
	<item>
		<title><![CDATA[High-tech swimsuits to keep records tumbling - expert]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200805/ai_n25441065]]></link>
		<description><![CDATA[PARIS AFP &#8212; New space-age swimsuits are the likely secret behind a recent spate of record-shattering swimming performances in the lead-up to this year's Beijing Olympic Games, researchers say.  Professor Jean-Francois Toussaint, author of a respected study on the limits of human physiology, recently had to update his statistics...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 19 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Lyon bid to bounce back from Cup heartbreak at Lens]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200801/ai_n21203721]]></link>
		<description><![CDATA[PARIS AFP &#8212; Six-time French champions Lyon will bid to consolidate their league lead with an away win against third-from-bottom Lens this weekend.  Lyon crashed out of the French League Cup midweek, a solitary goal from Japan midfielder Daisuke Matsui ensuring Le Mans' progression to the semi-finals.  But...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 19 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/champion.html"><![CDATA[champion]]></category>
		<category domain="http://resources.bnet.com/topic/games.html"><![CDATA[Games]]></category>
		<category domain="http://resources.bnet.com/topic/lens.html"><![CDATA[Lens]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinson's Disease]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200801/ai_n21919874]]></link>
		<description><![CDATA[To: NATIONAL EDITORS Contact: Media: Holly Barkhymer, +1-212-509-0995 x242, hbarkhymer@michaeljfox.org, or Research: Todd Sherer, PhD, +1-212- 509-0995 x243, tsherer@michaeljfox.org  NEW YORK,Jan. 4/PRNewswire-USNewswire/ --The Michael J. Fox Foundation has committed up to $3.8 million for the development of a gene silencing therapeutic to treat Parkinsons disease by reducing expression of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 04 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/gene.html"><![CDATA[gene]]></category>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/rna.html"><![CDATA[RNA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Multiple sclerosis: Early treatment slows progression]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200708/ai_n19402614]]></link>
		<description><![CDATA[PARIS AFP &#8212; Early use of the drug interferon beta-1b can significantly delay progression of multiple sclerosis MS, according to a study published in this Saturday's Lancet.  Swiss doctors conducted a trial among 468 patients diagnosed with early symptoms of MS, of whom 292 received the drug and 176...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 02 Aug 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Yin and Yang: Balance Could Play Key Role in Progression of Alzheimer's Disease.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200705/ai_n19751951]]></link>
		<description><![CDATA[M2 PRESSWIRE-30 May 2007-Rensselaer Polytechnic Institute: Yin and  Yang: Balance Could Play Key Role in Progression of Alzheimer's  DiseaseC1994-2007 M2 COMMUNICATIONS LTD    RDATE:29052007    Troy, N.Y. -- Researchers at Rensselaer Polytechnic Institute are  challenging current thinking on the causes and prevention of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 30 May 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/institute.html"><![CDATA[Institute]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/rensselaer+polytechnic+institute.html"><![CDATA[Rensselaer Polytechnic Institute]]></category>
		<category domain="http://resources.bnet.com/topic/researcher.html"><![CDATA[researcher]]></category>
		<category domain="http://resources.bnet.com/topic/yang.html"><![CDATA[Yang]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Next Pharmaceuticals Reveals NexrutineŽ Prevents Prostate Cancer Progression in Pre-clinical Animal Model]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_May_2/ai_n27223497]]></link>
		<description><![CDATA[University of Texas Study Demonstrates Effectiveness of Non-Toxic Botanical  SALINAS, Calif. -- Next Pharmaceuticals announced today the results of a study that an over-the-counter non-toxic botanical supplement, Nexrutine Phellodendron amurense, prevents the progression of prostate tumors in mice. The study was conducted in the laboratory of Dr. Pratap Kumar,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 May 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+texas.html"><![CDATA[University of Texas]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Newcastle aim for fourth successive win]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200511/ai_n15747712]]></link>
		<description><![CDATA[LONDON AFP &#8212; Newcastle have set their sights on a fourth successive victory as they attempt to continue their climb up the Premiership table at home to Birmingham on Saturday.  The Magpies made it into the top half last weekend with their resounding 3-0 win at West Brom as...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 03 Nov 2005 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[EUROPEAN PARLIAMENT]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4156/is_20051016/ai_n15709374]]></link>
		<description><![CDATA[STEWART FISHER    1. Have Artmedia exhausted their fund of Champions League shocks? Not yet, especially against an injury-hit Rangers. The Slovakians will be undaunted after Celtic Park and Porto, but may be more of a threat back in Bratislava.   2. Is Darren Fletcher's star turn...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 16 Oct 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/barcelona.html"><![CDATA[Barcelona]]></category>
		<category domain="http://resources.bnet.com/topic/european+parliament.html"><![CDATA[European Parliament]]></category>
		<category domain="http://resources.bnet.com/topic/fletcher.html"><![CDATA[Fletcher]]></category>
		<category domain="http://resources.bnet.com/topic/greece.html"><![CDATA[Greece]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/scotland.html"><![CDATA[Scotland]]></category>
		<category domain="http://resources.bnet.com/topic/team.html"><![CDATA[team]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Drug to slow progress of Alzheimer's on way.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4692/is_200508/ai_n17581430]]></link>
		<description><![CDATA[Aug 04, 2005 (The Mercury - ABIX via COMTEX) -- Australian  scientists have made an important        discovery that could facilitate  the         development of a drug to slow the progression    ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 04 Aug 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/toxin.html"><![CDATA[toxin]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+new+south+wales.html"><![CDATA[University of New South Wales]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Delay in Alzheimer's Disease Onset Seen for First Time; Neurologists May Have Foot in the Door to Preventing Alzheimer's Before It Starts.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5609/is_200504/ai_n23608092]]></link>
		<description><![CDATA[Byline: Mayo Clinic    ROCHESTER, Minn., April 11 AScribe Newswire -- A study led by  Mayo Clinic shows for the first time that a drug appears to have a  slowing effect -- though limited -- on the progression from mild  cognitive impairment to Alzheimer's disease....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 13 Apr 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[FADD Adaptor in Cancer]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=129991]]></link>
		<description><![CDATA[FADD Fas Associated protein with Death Domain is a key adaptor molecule transmitting the death signal mediated by death receptors. In addition, this multiple functional protein is implicated in survival/proliferation and cell cycle progression. FADD functions are regulated via cellular sublocalization, protein phosphorylation, and inhibitory molecules. The present review focuses...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 17 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[Progression]]></category>
		<category domain="http://resources.bnet.com/topic/protein.html"><![CDATA[Protein]]></category>
		<category domain="http://resources.bnet.com/topic/biomed+central.html"><![CDATA[BioMed Central]]></category>
		<category domain="http://resources.bnet.com/topic/molecule.html"><![CDATA[Molecule]]></category>
		<category domain="http://resources.bnet.com/topic/fadd+function.html"><![CDATA[FADD Function]]></category>
		<category domain="http://resources.bnet.com/topic/mice.html"><![CDATA[Mice]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[Hardware]]></category>
		<category domain="http://resources.bnet.com/topic/peripherals.html"><![CDATA[Peripherals]]></category>
	</item>
	<item>
		<title><![CDATA[Biogen and Elan: TYSABRI'R' Two-Year Monotherapy Trial Demonstrates Significant Impact on Disability Progression and Relapse Rate in Multiple Sclerosis.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200502/ai_n23472018]]></link>
		<description><![CDATA[CAMBRIDGE, MASSACHUSETTS and DUBLIN, IRELAND, Feb 17, 2005  CCNMatthews via COMTEX -- Data Show 42% Reduction in the Risk of  Disability Progression and Sustained 67% Reduction in Relapse Rate    CAMBRIDGE, MASSACHUSETTS and DUBLIN, IRELAND, Feb 17, 2005  CCNMatthews via COMTEX -- Data Show 42%...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 17 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="tickers">BIIB</category>
	</item>
	<item>
		<title><![CDATA[Pope clears schedule for coming days as flu takes a grip]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200502/ai_n13263939]]></link>
		<description><![CDATA[VATICAN CITY AFP &#8212; The Vatican said that Pope John Paul II had cancelled all his public appointments in the coming days because of the "progression" of his flu.  "As expected there is a continuing progression of the flu which has affected the Holy Father," Vatican spokesman Joaquin Navarro-Valls...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Feb 2005 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/pope.html"><![CDATA[Pope]]></category>
		<category domain="http://resources.bnet.com/topic/pope.html"><![CDATA[pope]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/spokesman.html"><![CDATA[spokesman]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Innovation In Performance Excellence: Eight Paradigms To Performance Excellence (8PPE)]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=162316]]></link>
		<description><![CDATA[The objective of this paper is to present a framework that describes a performance excellence system. Six Sigma is showcased as the operating system on which performance excellence methods may be launched. The framework for what should preclude Six Sigma is presented as well as what should follow. The integration...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Fri, 05 Nov 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/innovation.html"><![CDATA[Innovation]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[Progression]]></category>
		<category domain="http://resources.bnet.com/topic/performance.html"><![CDATA[Performance]]></category>
		<category domain="http://resources.bnet.com/topic/assessment+method.html"><![CDATA[Assessment Method]]></category>
		<category domain="http://resources.bnet.com/topic/performance+management.html"><![CDATA[Performance Management]]></category>
		<category domain="http://resources.bnet.com/topic/six+sigma.html"><![CDATA[Six Sigma]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/quality.html"><![CDATA[Quality]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
	</item>
	<item>
		<title><![CDATA[SAUDI ARABIA: UNEMPLOYMENT OF YOUNG PEOPLE IS WORST PROBLEM IN COUNTRY.(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6465/is_200410/ai_n25705471]]></link>
		<description><![CDATA[Al-Quds al-Arabi newspaper reported on unemployment among young  people which damages the orderly progression of life in the country. The  paper noted that that at the event of an opening of a branch of the  Swedish furniture store IKEA held in late August 2004 attended by about...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 13 Oct 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/furniture.html"><![CDATA[furniture]]></category>
		<category domain="http://resources.bnet.com/topic/ikea.html"><![CDATA[IKEA]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/unemployment.html"><![CDATA[unemployment]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[New Imaging Technology at Joslin Shown to Detect Early Signs of Type 1 Diabetes in Animal Models]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_Sept_1/ai_n6177893]]></link>
		<description><![CDATA[BOSTON -- By the time overt symptoms of type 1 diabetes appear in an individual, destruction of the insulin-producing beta cells of the pancreas has already progressed significantly. However, findings by researchers at Joslin Diabetes Center and Massachusetts General Hospital, published in the Aug. 24 issue of Proceedings of the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Sep 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/imaging.html"><![CDATA[imaging]]></category>
		<category domain="http://resources.bnet.com/topic/m.d..html"><![CDATA[M.D.]]></category>
		<category domain="http://resources.bnet.com/topic/massachusetts+general+hospital.html"><![CDATA[Massachusetts General Hospital]]></category>
		<category domain="http://resources.bnet.com/topic/researcher.html"><![CDATA[researcher]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Mouse Model Validation of PET in Breast Cancer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5979/is_200409/ai_n24155835]]></link>
		<description><![CDATA[In a study e-published ahead of print on July 26 in the Proceedings of the National Academy of Sciences of the USA, Abbey et al. from the University of California-Davis reported on the use of ^sup 18^F-FDG PET to monitor the longitudinal development of mammary intraepithelial neoplasia outgrowths in immunocompetent...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Sep 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/mice.html"><![CDATA[Mice]]></category>
		<category domain="http://resources.bnet.com/topic/mouse.html"><![CDATA[mouse]]></category>
		<category domain="http://resources.bnet.com/topic/national+academy+of+sciences.html"><![CDATA[National Academy of Sciences]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Biomira Inc. (Active Pharmaceutical Ingredient Watch).(Biomira Inc and Merck KGaA report that vaccine Theratope has failed two predetermined end points of time to disease progression and overall survival in a pivotal Phase III trial in metastatic breast c]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200306/ai_n13187343]]></link>
		<description><![CDATA[BIOMIRA Inc. and Merck KGaA report that vaccine Theratope has  failed two predetermined end points of time to disease progression and  overall survival in a pivotal Phase III trial in metastatic breast  cancer. Further analysis is underway of a ...    BIOMIRA Inc. and Merck...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 30 Jun 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[progression]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[A good fit: power FETs find their place. (Cover Story).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb094/is_200305/ai_n17427102]]></link>
		<description><![CDATA[EARLY IN THE PC's PROGRESSION into a mass-market consumer  product, Intel chose to focus on processor-clock speed as the key  indicator of performance. The headline figure in each generation climbed  through 90 and 100 MHz, made steady progress throug    EARLY IN THE PC's PROGRESSION...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 May 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/intel+corp..html"><![CDATA[Intel Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/pc.html"><![CDATA[PC]]></category>
		<category domain="http://resources.bnet.com/topic/performance.html"><![CDATA[performance]]></category>
		<category domain="http://resources.bnet.com/topic/processor.html"><![CDATA[processor]]></category>
		<category domain="http://resources.bnet.com/topic/progression.html"><![CDATA[Progression]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
		<category domain="tickers">INTC</category>
	</item>
</channel>
</rss>
